Modulation of cellular apoptotic potential: contributions to oncogenesis.
about
SH2-containing inositol 5'-phosphatase SHIP2 associates with the p130(Cas) adapter protein and regulates cellular adhesion and spreadingTransglutaminases: nature's biological gluesDifferential modulation of cellular death and survival pathways by conjugated bile acidsSMAC is expressed de novo in a subset of cervical cancer tumorsWnt/β-catenin signalling in prostate cancerThe role of PTEN in prostate cancer cell tropism to the bone micro-environment.Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of PtenHuman cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signalingLupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice.Theileria parva: taking control of host cell proliferation and survival mechanisms.Phosphatidylinositol 3-kinase and the control of endosome dynamics: new players defined by structural motifs.The Rho Guanine Nucleotide Exchange Factor DRhoGEF2 Is a Genetic Modifier of the PI3K Pathway in DrosophilaThalidomide induces limb anomalies by PTEN stabilization, Akt suppression, and stimulation of caspase-dependent cell deathThe p85alpha subunit of class IA phosphatidylinositol 3-kinase regulates the expression of multiple genes involved in osteoclast maturation and migration.PI3-kinase inhibition synergistically promoted the anti-tumor effect of lupeol in hepatocellular carcinomaCD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis.FoxO1 mediates PTEN suppression of androgen receptor N- and C-terminal interactions and coactivator recruitment.Distinct roles of the ERK pathway in modulating apoptosis of Ras-transformed and non-transformed cells induced by anticancer agent FR901228.Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors.Enhanced cell growth inhibition following PTEN nonviral gene transfer using polyethylenimine and photochemical internalization in endometrial cancer cells.Inhibitory mechanisms of tea polyphenols on the ultraviolet B-activated phosphatidylinositol 3-kinase-dependent pathway.UV-B Induced stimulation of phosphatidylinositol 3-kinase in human fetal hepatocytes.Stoichiometric quantification of Akt phosphorylation using LC-MS/MS.DVL as a scaffold protein capturing classical GPCRs.Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors.Adenosine A(3) receptor activation protects the myocardium from reperfusion/reoxygenation injury.NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.Transcriptional regulation of pro-apoptotic Par-4 by NF-kappaB/p65 and its function in controlling cell kinetics during early events in endometrial tumourigenesis.The Akt/PKB pathway is constitutively activated in Theileria-transformed leucocytes, but does not directly control constitutive NF-kappaB activation
P2860
Q24290742-8C4E6565-A77F-40DF-92D9-D5BB9F86245BQ24534936-EB093B79-4582-4AB9-8838-95010D027BE6Q24794253-2C3F474F-BB91-463C-9F88-F7D61F60D54BQ24804096-D0084CE9-C6F3-4E5F-85FF-01102294C866Q28269116-7D74E1F9-9C51-4616-8CC8-969922B90CB5Q30443138-B25F84D3-D7C5-49E0-8C5D-DADEC394CDD1Q30524175-A50043C5-233B-4E7E-B314-AD4CB6DA6B82Q33842473-B7C2C0BB-6F0C-49AC-B138-99C7C58F2F2BQ33977990-9826F9D6-6E16-4141-B4EB-93BFDDCCACD2Q34156250-B39CCE57-D28F-4C09-BAF5-18F2D6BA349DQ34459677-C7F3D833-7FD7-4766-9594-424AF2037F95Q35970384-6C78CA15-3D6A-46F8-A863-36C2F3056D79Q36421389-58E0C202-0D2D-4AFB-94CD-BA609D832D3CQ36994766-3CD18C0B-69A9-4013-AAA8-0592413784C3Q37323327-5C2724CD-7574-4E4B-8509-8ED0A1C3D797Q38289911-3199FFC8-055E-4726-8170-C55600F7B028Q39906248-6AB5B991-FFC1-4F44-9CFF-A3CB762940B5Q40476887-2179669F-3744-48D3-8F48-3D142377A205Q40486178-2C59081F-B768-4129-9682-C2E820ADB661Q40509977-36BDA136-9931-4C2B-8B99-87E8108EBF05Q40776146-206C3CB0-A8CD-4901-B3E1-6632A4700C32Q41813117-2D704926-E999-4079-A524-A54C038B7E2CQ42037906-6B286A40-EF29-49F1-81B5-2622BD8C4CD3Q42598026-9C40054F-DF35-4FFA-8B4F-8EA2ACAAE6F9Q43571535-A1F333B1-BF42-4541-B6A8-B08F686EB1C3Q44138371-E677998F-9ADB-4A5D-A412-DFDC33203380Q45982548-C944AD6F-E13D-4E15-B3AB-796B0D296D3DQ53301550-5B575AE4-AD1B-438F-890E-90E9E0297FF7Q58825235-5273CADD-FA75-4147-9662-9D4459D355E9
P2860
Modulation of cellular apoptotic potential: contributions to oncogenesis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Modulation of cellular apoptotic potential: contributions to oncogenesis.
@ast
Modulation of cellular apoptotic potential: contributions to oncogenesis.
@en
type
label
Modulation of cellular apoptotic potential: contributions to oncogenesis.
@ast
Modulation of cellular apoptotic potential: contributions to oncogenesis.
@en
prefLabel
Modulation of cellular apoptotic potential: contributions to oncogenesis.
@ast
Modulation of cellular apoptotic potential: contributions to oncogenesis.
@en
P2093
P2860
P356
P1433
P1476
Modulation of cellular apoptotic potential: contributions to oncogenesis.
@en
P2093
J R Woodgett
V Stambolic
P2860
P2888
P304
P356
10.1038/SJ.ONC.1203126
P407
P577
1999-11-01T00:00:00Z
P5875
P6179
1012402646